Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

BACKGROUND: The Xpert MTB/RIF (Cepheid) non-laboratory-based molecular assay has potential to improve the diagnosis of tuberculosis (TB), especially in HIV-infected populations, through increased sensitivity, reduced turnaround time (2 h), and immediate identification of rifampicin (RIF) resistance....

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Lesley E., McCarthy, Kerrigan, Gous, Natasha, Nduna, Matilda, Van Rie, Annelies, Sanne, Ian, Venter, Willem F., Duse, Adrian, Stevens, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144192/
https://www.ncbi.nlm.nih.gov/pubmed/21814495
http://dx.doi.org/10.1371/journal.pmed.1001061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144192/
https://www.ncbi.nlm.nih.gov/pubmed/21814495
http://dx.doi.org/10.1371/journal.pmed.1001061

Ejemplares similares